RCaz/eu-funding-proposals-sft huggingface dataset:
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Compose a compelling abstract for 'Towards gamma-ray lasers via super-radiance in a Bose-Einstein condensate of 135mCs isomers' demonstrating excellence, impact and implementation quality for a Horizon 2020 call.

assistant: **Abstract**

We propose to realise the first experimental demonstration of gamma-ray coherent emission by means of super-radiance in a Bose-Einstein condensate of 135mCs isomers. The isomers will be produced by proton bombardment and will be then laser cooled and trapped in a magneto-optical trap. The cold atomic sample will be transferred to an optical dipole trap, where, by means of forced evaporative cooling, a Bose-Einstein Condensate will be realised. The 135mCs condensate will satisfy the requirements for gamma-ray coherent emission at 787 keV. The project will lead to several milestones in fundamental physics, thus triggering further novel researches, and will demonstrate the practical feasibility of gamma-ray lasers, that would have numerous potential applications ranging from energy industry to medicine.
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Compose a compelling abstract for 'Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS' demonstrating excellence, impact and implementation quality for a Horizon Europe call.

assistant: **Abstract**

The ARISTOTELES project aims to build a multinational harmonized data platform to develop and implement novel artificial intelligence (AI) approaches for management of complex diseases, where progression and manifestations of comorbidities are via multiple interacting pathways. We aim to apply our novel approach to a population of great need due to atrial fibrillation (AF), but our outputs can be extended to other complex diseases with multimorbidity. By integrating AIs into clinical practice, our platform will form a backbone for acceptable, responsible, and respectful uses of patient/participant data to develop and validate novel trustworthy AI tools for more personalized risk assessment and management. This represents a paradigm shift in AF treatment, moving from a focus on individual risk factors and selected outcomes (eg. stroke) to a holistic approach, underpinning timely diagnostic and therapeutic interventions to reduce disease progression, disability, hospitalizations and mortality, as well as improve patient adherence to lifestyle modifications, medications, and other treatment regimens.ARISTOTELES will be delivered through 8 inter-linking work-packages (WPs): WP1 is study management/coordination. WP2 provides the ethical/legal requirements for the development of a trustworthy AI. WP3 addresses stakeholder understanding of AI, needs assessment, and engagement in all the phases of the AI development. In WP4, granular data on genotype and phenotype characteristics, are harmonized from different datasets into a common platform. In WP5, AI algorithms/tools are developed and connected to an interactive output interface for patients and clinicians. In WP6, we test the AI tool developed in WP5 in a clinical trial simulation (in silico trial). In WP7 a multicenter ran
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe the specific objectives and expected outcomes for 'DNA damage responses, Genomic instability and Radiation-Induced Cancer: The problem of risk at low and protracted doses (RISC-RAD)' in the context of a Sixth Framework call.

assistant: **Objectives**

Radiation protection requires a thorough understanding of low dose ionising radiation. Currently extrapolation from high doses is necessary to estimate the effects of low doses. Furthermore, it is critically important to have an appreciation of the variation in individual responses to radiation among the human population. Present estimates of the risks from radiation exposure are based largely on the average" individual in an exposed population. However, clinical observations of adverse reactions to radiotherapy indicate large variations in individual radiosensitivity. Quantification of risk requires the identification of new parameters taking into account these differences in radiation responses. Therefore, a detailed knowledge of the mechanisms by which radiation induces cancer is essential. In this project, leading European research teams join forces to understand the various steps involved in the multistage process of radiation-induced tumourigenesis through detailed analysis of DNA damage responses (repair, checkpoints, apoptosis), genomic instability as well as mechanisms/genetics and modelling of radiation tumourigenesis. The research in this project will answer the following specific questions: (i) Who is at risk? (ii) When do the factors modifying risk exert their influence? (iii) What are the mechanisms through which risk factors act? (iv) Is there a link between radiosensitivity of individuals (short term) and susceptibility to cancer (Late after exposure)? The consortium will apply innovative and state of the art technology (genomics, proteomics, advanced fluorescence microscopy, RNA interference, gene knock-in technology). We stress that the identification of genetic variables in the processing of radiation induced DNA damage is vital for re-evaluation of c
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Write the 'Expected Impact' section for the project 'Aggressive T cell Lymphomas, integrated clinical and genomic analysis for a precision medicine.' (PRECISMEDLYM), addressing dissemination and exploitation.

assistant: **Impact**

Lymphoid leukemias and lymphomas represent frequent areas of the tumour pathology. Recent Integrative clinical and molecular studies allows to identify concrete disorders where a precise recognition leads to a specific treatment with a minimum toxicity and maximum clinical benefit. Even though there have been many progress during last years, there still persist numerous conditions with low survival probability and high side effects of the received treatments. The introduction of the precision medicine in lymphoid neoplasms is new and challenging due to the scarce knowledge about disease pathogenesis, targeted therapies and predictor markers, immunotherapy role and poor experimental models.T-cell lymphoma tumors present a dismal survival probability dismal (25% for Peripheral T-cell lymphoma) in patients, and the molecular mechanism underlying their high rate of lack response to treatments and relapse is poorly understood.  Furthermore, patients with lymphoproliferative disorders often have complex (multiclonal) or mixed lymphoproliferative disorders.This project aim the consolidation of the precision medicine in the diagnosis and therapy of these disorders, thus facilitating the treatment of each patient according its disease, with specific therapy according to the integral characterization of its disease, thus reducing toxicity and improving the therapy efficacy.The project focuses on complex lymphoproliferative diseases characterized by clinical aggressiveness with low therapeutic response, tumor heterogeneity and patterns of dependency / interaction with the microenvironment. The success of the project requires in first instance to improve in the knowledge of the molecular basis of the disease and subsequently in the identification of precise tumour types and patient
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Compose the 'Concept and Approach' section for a Seventh Framework proposal on 'Products from methanol by synthetic cell factories'.

assistant: **Concept**

There is a high societal need for a sustainable production of key chemistry, food and health care compounds. Microbial cell factories are logical production systems, but up to now they use sugars and other food derived raw materials as substrates. Sugars originating from plants demand cultivable land which is more and more needed for human nutrition. Methanol - with a worldwide production capacity of more than 46 million tons per year - is regarded as an alternative highly attractive raw material in microbial fermentation for the manufacturing of special, fine, bulk, and fuel chemicals. This is especially true for the EU market, where industrial biotechnology still is hampered by strict use and price regulations as well as import limitations for agricultural commodities, such as corn or sugar. The supply of methanol can base upon both fossil and renewable resources, rendering it a highly flexible and sustainable raw material. Our vision is a viable methanol-based European bio-economy, which we will promote by for the first time applying synthetic biology principles for cell factory development in order to harness methanol as a general feedstock for the manufacturing of special and fine chemicals. In nature, methylotrophic microorganisms can utilize methanol as their sole source of carbon and energy. The project PROMYSE will deliver an alternative route to sought-after chemicals, with a major focus on terpenoids. PROMYSE combines two frontline research topics: orthogonal modularization of methylotrophy within a Synthetic Biology concept and employing methanol as a feedstock for biotechnological production. Through the transfer of methylotrophy modules, Synthetic Biology will pave the way to capitalize on the metabolic versatility and engineered production pathways of gen
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Draft the 'Objectives and Scope' section of a Horizon 2020 proposal for the project 'New process for efficient CO2 capture by innovative adsorbents based on modified graphene aerogels and MOF materials'.

assistant: **Objectives**

Global warming resulting from the emission of greenhouse gases has received widespread attention with international action from governments and industries, including a number of collaborative programs, such as SET-Plan, and very recently the International Climate Change hold 2015 in Paris. Key European Commission roadmaps towards 2030 and 2050 have identified Carbon Capture and Storage (CCS) as a central low-carbon technology to achieve the EU’s 2050 Greenhouse Gas (GHG) emission reduction objectives, although there still remains a great deal to be done in terms of embedding CCS in future policy frameworks. The selective capture and storage of CO2 at low cost in an energy-efficient is a world-wide challenge. One of the most promising technologies for CO2 capture is adsorption using solid sorbents, with the most important advantage being the energy penalty reduction during capture and regeneration of the material compared to liquid absorption. The key objectives of GRAMOFON projects are: (i) to develop and protoype a new energy and cost-competitive dry separation process for post-combustion CO2 capture based on innovative hybrid porous solids Metal organic frameworks (MOFs) and Graphene Oxide nanostructures.(ii) to optimize the CO2 desorption process by means of Microwave Swing Desorption (MSD) and Joule effect,  that will surpass the efficiency of the conventional heating procedures.This innovative concept will be set up by world key players expert in synthesis, adsorption, characterization and modelling, as well as process design and economic projections.
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Explain the overall concept, methodology and approach for the project 'Role of plasmacytoid dendritic cells in the orchestration of in vivo immune responses' (ORCHESTRATE).

assistant: **Concept**

Plasmacytoid dendritic cells (pDCs) which are professional type I IFN producing cells modulate phenotype and function of conventional dendritic cells (cDCs) triggering maturation and enhancing priming of cytotoxic T lymphocytes (CTLs). It is widely accepted that type I IFNs offer a link between innate and adaptive immune responses, but there are contrasting data regarding their immunoregulatory effects. It has been shown that pDC derived IFNs modulate the phenotype and function of conventional DCs. Moreover, pDCs and cDCs contribute to the activation of NK cells. Ability of pDC to function as APC for T cells is also demonstrated. Thus pDC appear specialized for initiation of innate response, but also have certain capabilities of inducing and modulating adaptive immune responses.Recent work from Albert group provided a first-generation multi-analyte profile (MAP) of how pDCs serve to bridge innate and adaptive immune responses in the context of TLR7 and TLR9 agonists analysing in vitro human isolated pDCs. Four distinct cytokine/chemokine loops by wich pDCs contribute to the initiation of an inflammatory response were identified, what helped to provide a foundation for understanding the functional status of pDCs in different disease states.To understand the impact of inflammatory response on the coordination of immune responses, to define the mechanism by which innate effector molecules influence adaptive immunity at a fundamental level, in vivo research on mouse models is required. Thusfar mice strain that permit control of gene expression in pDCs has not been used. The Albert lab developed Siglec-H-CreERT2 knock-in mice with pDC specific inducible Cre expression. A second knock-in was developed in order to control the production of type I IFNs – Siglec-H-IRF-7. By usin
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe how 'AbilityPharma: Accelerating Solutions for Pancreatic Cancer' will create measurable scientific, societal and economic impact aligned with Horizon 2020.

assistant: **Impact**

ABTL0812 is a first-in-class fully differentiated oral targeted anticancer compound that produces autophagy-mediated cytotoxicity selectively in cancer cells. In preclinical studies, ABTL0812 showed efficacy as a single agent and in combination with current standard-of-care treatments in in vitro and animal models of pancreatic cancer, an orphan disease with an urgent unmet clinical need for new efficacious and safe therapies. Treatment with ABTL0812 induced tumor regression without increasing the toxicity associated with chemotherapy. These results granted an Orphan Drug Designation (ODD) to ABTL0812 for pancreatic cancer treatment from the EMA and the FDA.Moreover, ABTL0812 is a clinical stage drug. A first-in-human phase 1/1b clinical trial, designed to evaluate ABTL0812 in 29 cancer patients with advanced solid tumors, demonstrated that the drug was safe and well tolerated and no dose-limiting toxicities were reported. In addition, two patients showed 14-month and 18-month disease stabilization (TRL7). AbilityPharma’s objectives for the present project are to complete the next stage of the clinical development of its first drug candidate ABTL0812, a potential game changer in the treatment of pancreatic cancer, and to commercialize the results of the study through a licensing agreement. AbilityPharma will start a phase 2 clinical trial in pancreatic cancer to investigate ABTL0812 in combination with the standard-of-care chemotherapy, which has the potential to address this urgent unmet medical need by providing a safe and efficacious treatment. After finishing the clinical trial (TRL8), we will establish a partnership (licensing deal) with a big pharma partner which will further develop ABTL0812 to make it available to pancreatic cancer patients (TRL9). Finally, once
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe how 'Phycosphere Epibionts-mEdiated Resistance againSt fungi' will create measurable scientific, societal and economic impact aligned with Horizon Europe.

assistant: **Impact**

Symbionts are essential components of healthy organisms, assuming functions often mediated by chemical communication. In aquatic environments, microbial primary producers such as phytoplankton possess complex epibiotic bacterial communities that contribute to their physiology by secretion of bioactive molecules. However, the role of symbiotic bacteria in mediating the host’s interaction with other coexisting microbes is poorly studied. PEERS’ aim is to unravel the key symbionts of phytoplankton mediating host interaction with zoosporic fungal parasites through the biosynthesis of antifungal compounds. Using a tripartite interaction model involving phytoplankton host, bacterial symbionts and fungal parasites, we will study (i) the diversity of bacteria associated with healthy and diseased host populations, and (ii) the symbionts’ biosynthesis of antifungal compounds. This study integrates molecular ecology, metabolomics, and bioactivity screenings coupled with advanced statistics and data processing methods. Aquatic microbial communities will be collected from the Baltic Sea during the secondment, where the phytoplankton-host and parasite interactions during fungal disease outbreaks are well documented. PEERS will address a fundamental ecological question about the role of symbiotic bacteria in driving host-fungal parasite interaction in the aquatic environment, providing critical knowledge for understanding future variations in aquatic biomes under current environmental changes. Additionally, it provides a perfect model system to discover antifungal chemical signals with industrial applications. PEERS offers cutting-edge training opportunities to generate results at the forefront of innovation in aquatic ecology and biotechnology. Moreover, it offers transdisciplinary n
system: You are an expert grant writer specializing in European Union research funding proposals. You write compelling, well-structured proposal sections that demonstrate excellence, impact, and implementation quality, using precise EU terminology and following best practices for Horizon Europe, Horizon 2020, and earlier framework programmes.

user: Describe how 'Extracellular Vesicles for Bone Regeneration – alternatives to Stem-cell Therapy' will create measurable scientific, societal and economic impact aligned with Horizon 2020.

assistant: **Impact**

The therapeutic benefits of mesenchymal stem cells (MSCs), the state-of-the-art treatment for healing bone defects following trauma, resection of cancerous bone tumors, or metabolic bone diseases, has been attributed to their secreted factors. The regenerative potential of MSC-secreted extracellular vesicles (EVs), nanoparticles which deliver bioactive cargo (nucleic acids, proteins, and lipids) between cells, has recently been reported. The applicant will embark upon frontier research with the objective of progressing beyond the state-of-the-art, by harnessing the therapeutic effects of MSCs, but in a cutting-edge, cell-free manner, by developing high potency EV-based bone replacements. This objective will be addressed by firstly testing novel hypotheses to delineate how culture environments, specifically mechanical cues (substrate elasticity and 3D dynamic), hypoxia, and cell stress can modulate the cargo of EVs secreted by MSC. Size exclusion chromatography, which separates EVs from soluble proteins will be employed. Heterogeneity of EV cargo and functionality between human MSC donors will also be evaluated. Answering these hypotheses will permit the intelligent design of targeted EV therapies. The hypothesis that EV-functionalized constructs, fabricated by 3D-printing, will lead to controlled and sustained release of EVs and induce bone formation in vivo will best tested. Together, this will answer critical questions, namely the most favorable environment for collection of potent EVs for regenerative medicine, which secretome component (EV, soluble factors) is responsible for bone regeneration, and whether MSC cell therapy can be replaced by cell-free EVs. EVEREST will develop a platform for targeted EV delivery in ground-breaking, easy to transport and handle, ‘off